Estados Unidos · Plataformas y datos · MarketBeat
Exelixis Eyes Q1 Zanza Data as It Plans Beyond CABO

Resumen detallado
Exelixis (NASDAQ:EXEL) is preparing for a transition from a company built around its CABO franchise to one with multiple products, as it advances seven pivotal studies of Zanza and weighs additional development opportunities, Chief Strategy Officer Andrew Peters said at the Jefferies London Healthca
MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.marketbeat.com)




